Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of July 2020 (specifically referencing Q1 FY2021 Results Notifications)
Principal Executive Offices: Dublin, Ireland
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific financial data tables or numerical values. Consequently, the following metrics are not available in this text:
- Revenue: Not provided.
- Profit: Not provided.
- Cash Flow: Not provided.
- Margins: Not provided.
- Debt and Liquidity: Not provided.
The filing references "Q1 FY2021 Results Notifications" as Exhibit 99.1, but the content of that exhibit is not included in the source text.
Material Changes
The filing text does not provide comparative financial data or specific details on material changes versus prior periods. It notes that the company operates in regions affected by the COVID-19 public health crisis, which is expected to have a significant negative impact on business, sales, and results of operations.
Guidance, Outlook, and Risks
Forward-Looking Statements: The document contains extensive forward-looking statements regarding future performance, capital expenditure, credit facilities, dividends, and the integration of Fermacell. Management cautions that actual results may differ materially due to inherent risks.
Key Risks and Contingencies:
- COVID-19: Significant negative impact expected on sales, operations, and financial condition.
- Asbestos Liability: Risks related to the Asbestos Injuries Compensation Fund (AICF), including contribution shortfalls and currency exchange rate effects on liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings.
- Market Conditions: Dependence on residential and commercial construction markets, housing affordability, and raw material costs.
- Financial Structure: Risks regarding the renewal of credit facilities and the transition from LIBOR.
Investor Verification Checklist
- Verify the specific financial results for Q1 FY2021 by reviewing the full text of Exhibit 99.1 (Q1 FY2021 Results Notifications), which is referenced but not included in this filing.
- Assess the quantified impact of the COVID-19 pandemic on the company's revenue and operational capacity as detailed in the full results notification.
- Review the latest status of the Asbestos Injuries Compensation Fund (AICF) and any required additional contributions.
- Confirm the company's liquidity position and the status of credit facility renewals in light of current market conditions.
- Monitor updates on the integration of Fermacell and associated capital expenditure projects.